In this article, we uncovered inhibition of RAC1 in lung cancer cells is sufficient to abrogate the IR-induced and RAC1-mediated tumor migration and invasion, as evidenced by cell proliferation, colony formation, and Transwell assay. The gene discussed is RAC1; the disease is lung carcinoma.